Medical device manufacturer using neuromodulation (electricity) to cure blindness-causing diseases like Macular Degeneration.
We are treating diseases with huge and growing markets where there are limited if any approved cures or therapies. Macular Degeneration is a one in three person disease. We are approved and selling in countries outside of the USA, and are close to FDA approval. We are seeking up to $6 million to complete FDA approval, additional clinical work, and to continue commercialization activites. Our market cap potential is in the $billions